From the CEO. Its aspirational for sure. He mentions it in the EGM video.
If we are blockbuster MND and somehow demonstrate strong likelihood of impacting other larger scale neurodegenerative diseases in parallel....well then being a $5b company is credible...
BUT first hurdle....are we significantly better than SOC for MND now? I think we are. I think we are all about to be amazed at what MPL can do for these unfortunate sufferers of this disease.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-375
-
- There are more pages in this discussion • 1,050 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |